Cargando…

A Rapid Lysostaphin Production Approach and a Convenient Novel Lysostaphin Loaded Nano-emulgel; As a Sustainable Low-Cost Methicillin-Resistant Staphylococcus aureus Combating Platform

Staphylococcus aureus is a Gram-positive pathogen that is capable of infecting almost every organ in the human body. Alarmingly, the rapid emergence of methicillin-resistant S. aureus strains (MRSA) jeopardizes the available treatment options. Herein, we propose sustainable, low-cost production of r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nour El-Din, Hanzada T., Elhosseiny, Noha M., El-Gendy, Mohamed A., Mahmoud, Azza A., Hussein, Manal M. M., Attia, Ahmed S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175171/ https://www.ncbi.nlm.nih.gov/pubmed/32178236 http://dx.doi.org/10.3390/biom10030435

Ejemplares similares

Lysostaphin: an enzymatic approach to staphylococcal disease. 3. Combined lysostaphin-methicillin therapy of established staphylococcal abscesses in mice.
por: Dixon, R. E., et al.
Publicado: (1968)

Recombinant Lysostaphin Protects Mice from Methicillin-Resistant Staphylococcus aureus Pneumonia
por: Chen, Chen, et al.
Publicado: (2014)

Structural and Functional Insights Into Lysostaphin–Substrate Interaction
por: Tossavainen, Helena, et al.
Publicado: (2018)

The Influence of Dimerization on the Pharmacokinetics and Activity of an Antibacterial Enzyme Lysostaphin
por: Grishin, Alexander V., et al.
Publicado: (2019)

In vitro activity of recombinant lysostaphin in combination with linezolid, vancomycin and oxacillin against methicillin-resistant Staphylococcus aureus
por: Narasimhaswamy, Nagalakshmi, et al.
Publicado: (2017)

Lysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications
por: Bastos, Maria do Carmo de Freire, et al.
Publicado: (2010)

A Simple Protocol for the Determination of Lysostaphin Enzymatic Activity
por: Grishin, Alexander V., et al.
Publicado: (2020)

Lysostaphin: an enzymatic approach to staphylococcal disease. II. In vivo studies.
por: Schaffner, W., et al.
Publicado: (1967)

Lysostaphin: an enzymatic approach to staphylococcal disease. I. In vitro studies.
por: Schaffner, W., et al.
Publicado: (1967)

Two site recognition of Staphylococcus aureus peptidoglycan by lysostaphin SH3b
por: Gonzalez-Delgado, Luz S., et al.
Publicado: (2019)

Anti-staphylococcal activities of lysostaphin and LytM catalytic domain
por: Sabala, Izabela, et al.
Publicado: (2012)

Cloning, Expression, and Purification of Recombinant Lysostaphin From Staphylococcus simulans
por: Farhangnia, Leila, et al.
Publicado: (2014)

Crystal structure of the antimicrobial peptidase lysostaphin from Staphylococcus simulans
por: Sabala, Izabela, et al.
Publicado: (2014)

Clinical efficacy of intravaginal recombinant lysostaphin administration on endometritis in sows
por: Ye, Guizi, et al.
Publicado: (2021)

Antibacterial and Anti-Biofilm Properties of Diopside Powder Loaded with Lysostaphin
por: Kudinova, Alina, et al.
Publicado: (2023)

The bactericidal effect of lysostaphin coupled with liposomal vancomycin as a dual combating system applied directly on methicillin-resistant Staphylococcus aureus infected skin wounds in mice
por: Hajiahmadi, Fahimeh, et al.
Publicado: (2019)

Thermally triggered release of the bacteriophage endolysin CHAP(K) and the bacteriocin lysostaphin for the control of methicillin resistant Staphylococcus aureus (MRSA)
por: Hathaway, Hollie, et al.
Publicado: (2017)

Structural bases of peptidoglycan recognition by lysostaphin SH3b domain
por: Mitkowski, Paweł, et al.
Publicado: (2019)

In Vitro and in Vivo Antistaphylococcal Activity Determination of the New Recombinant Lysostaphin Protein
por: Abtahi, Hamid, et al.
Publicado: (2016)

Synergistic Anti-Staphylococcal Activity Of Niosomal Recombinant Lysostaphin-LL-37
por: Sadeghi, Somayeh, et al.
Publicado: (2019)

Draft Genome Sequences of Lysostaphin-Resistant (K07-204) and Lysostaphin-Susceptible (K07-561) Staphylococcus aureus Sequence Type 72 Strains Isolated from Patients in South Korea
por: Batool, Nayab, et al.
Publicado: (2020)

OP3: Current Efficacy of Lysostaphin Against Staphylococcus Aureus Strains Relevant for Burned Patients
por: Lipový, Breta, et al.
Publicado: (2022)

Hydrogel delivery of lysostaphin eliminates orthopedic implant infection by Staphylococcus aureus and supports fracture healing
por: Johnson, Christopher T., et al.
Publicado: (2018)

Design and High Expression of Non-glycosylated Lysostaphins in Pichia pastoris and Their Pharmacodynamic Study
por: Shen, Wenluan, et al.
Publicado: (2021)

Lysostaphin-Coated Titan-Implants Preventing Localized Osteitis by Staphylococcus aureus in a Mouse Model
por: Windolf, Ceylan D., et al.
Publicado: (2014)

Comparative Transcriptome Analysis Reveals Differentially Expressed Genes Related to Antimicrobial Properties of Lysostaphin in Staphylococcus aureus
por: Yan, Xianghe, et al.
Publicado: (2022)

In vivo efficiency of the produced recombinant lysostaphin antimicrobial peptide in treatment of methicillin-resistant Staphylococcus aureus (MRSA) skin infection in a mouse model
por: Sadoogh Abbasian, Shabnam, et al.
Publicado: (2023)

Cloning and expression of Staphylococcus simulans lysostaphin enzyme gene in Bacillus subtilis WB600
por: Far, Babak Elyasi, et al.
Publicado: (2021)

Zinc-finger nickase-mediated insertion of the lysostaphin gene into the beta-casein locus in cloned cows
por: Liu, Xu, et al.
Publicado: (2013)

Structure-based redesign of lysostaphin yields potent antistaphylococcal enzymes that evade immune cell surveillance
por: Blazanovic, Kristina, et al.
Publicado: (2015)

Identification and structural characterization of LytU, a unique peptidoglycan endopeptidase from the lysostaphin family
por: Raulinaitis, Vytas, et al.
Publicado: (2017)

Globally deimmunized lysostaphin evades human immune surveillance and enables highly efficacious repeat dosing
por: Zhao, Hongliang, et al.
Publicado: (2020)

Antimicrobial peptidase lysostaphin at subinhibitory concentrations modulates staphylococcal adherence, biofilm formation, and toxin production
por: Yue, Yuan, et al.
Publicado: (2023)

Lysostaphin and BMP-2 co-delivery reduces S. aureus infection and regenerates critical-sized segmental bone defects
por: Johnson, Christopher T., et al.
Publicado: (2019)

Fusion of Lysostaphin to an Albumin Binding Domain Prolongs Its Half-Life and Bactericidal Activity in the Systemic Circulation
por: Grishin, Alexander V., et al.
Publicado: (2019)

Functional Identification of Serine Hydroxymethyltransferase as a Key Gene Involved in Lysostaphin Resistance and Virulence Potential of Staphylococcus aureus Strains
por: Batool, Nayab, et al.
Publicado: (2020)

Phenotype-Genotype Characterization and Antibiotic-Resistance Correlations Among Colonizing and Infectious Methicillin-Resistant Staphylococcus aureus Recovered from Intensive Care Units
por: Nour El-Din, Hanzada T, et al.
Publicado: (2021)

A Novel Controlled-Release System for Antibacterial Enzyme Lysostaphin Delivery Using Hydroxyapatite/Chitosan Composite Bone Cement
por: Xue, Bai, et al.
Publicado: (2014)

Industrial-scale production and purification of a heterologous protein in Lactococcus lactis using the nisin-controlled gene expression system NICE: The case of lysostaphin
por: Mierau, Igor, et al.
Publicado: (2005)

Antibiotic Resistance in Staphylococcus aureus Strains Isolated from Cows with Mastitis in Eastern Poland and Analysis of Susceptibility of Resistant Strains to Alternative Nonantibiotic Agents: Lysostaphin, Nisin and Polymyxin B
por: SZWEDA, Piotr, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_64jko77tbsn6g4r0tqjvht7v0j